SFX by Ex Libris Inc.

Title:	High-throughput assay for the identification of Hsp90 inhibitors based on Hsp90-dependent refolding of firefly luciferase
Source:	Bioorganic & Medicinal Chemistry [0968-0896] Galam, Lakshmi yr:2007

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Frydman, J. "Co-translational domain folding as the structural basis for the rapid de novo folding of firefly luciferase." Nature structural biology 6.7 (1999): 697-705.
description	2.	Smith, V. "Comparison of 17-dimethylaminoethylamino-17-demethoxy-geldanamycin (17DMAG) and 17-allylamino-17-demethoxygeldanamycin (17AAG) in vitro: effects on Hsp90 and client proteins in melanoma models." Cancer chemotherapy and pharmacology 56.2: 126-137.
description	3.	Tyukhtenko, S. "Characterization of the Neuron-Specific L1-CAM Cytoplasmic Tail: Naturally Disordered in Solution It Exercises Different Binding Modes for Different Adaptor Proteins." Biochemistry 47.13 (2008): 4160-8.
description	4.	Duvvuri, M. "A new approach for enhancing differential selectivity of drugs to cancer cells." ACS Chemical Biology 1.5 (2006): 309-15.
description	5.	Georgakis, Georgios V V. "The HSP90 inhibitor 17-AAG synergizes with doxorubicin and U0126 in anaplastic large cell lymphoma irrespective of ALK expression." Experimental hematology 34.12 (2007): 1670-9.
description	6.	Nicola, A. "Co-translational folding of an alphavirus capsid protein in the cytosol of living cells." Nature cell biology 1.6 (1999): 341-345.
description	7.	Kamal, A. "A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors." Nature 425.6956 (2003): 407-10.
description	8.	Fedorov, A. "Process of biosynthetic protein folding determines the rapid formation of native structure." Journal of molecular biology 294.2 (1999): 579-586.
description	9.	Wu, W. "Geldanamycin and its analog induce cytotoxicity in cultured human retinal pigment epithelial cells." Experimental Eye Research 91.2 (2010): 211-219.
description	10.	Chiosis, G. "Tumor selectivity of Hsp90 inhibitors: the explanation remains elusive." ACS Chemical Biology 1.5 (2006): 279-284.
description	11.	Kramer, G. "The ribosome as a platform for co-translational processing, folding and targeting of newly synthesized proteins." Nature Structural & Molecular Biology 16.6 (2009): 589-597.
description	12.	Lattouf, Leonard B. "Mechanisms of disease: the role of heat-shock protein 90 in genitourinary malignancy." Nature Reviews Urology 3.11 (2006): 590-601.
description	13.	Cysyk, Richard L L. "Reaction of geldanamycin and C17-substituted analogues with glutathione: product identifications and pharmacological implications." Chemical research in toxicology 19.3 (2006): 376-81.
description	14.	Schumacher, Jonathan A A. "Proteome-wide changes induced by the Hsp90 inhibitor, geldanamycin in anaplastic large cell lymphoma cells." Proteomics 7.15 (2007): 2603-16.
description	15.	Buhusi, M. "L1 interaction with ankyrin regulates mediolateral topography in the retinocollicular projection." The journal of neuroscience 28.1 (2007): 177-88.
description	16.	Gazdoiu, M. "MAP kinase pathway-dependent phosphorylation of the L1-CAM ankyrin binding site regulates neuronal growth." Molecular biology of the cell 17.6 (2006): 2696-706.
description	17.	Yun, E. "Individual Acidic Organelle pH Measurements by Capillary Electrophoresis." Analytical chemistry 78.3 (2006): 820-826.
description	18.	Deshmukh, L. "Structural insight into the interaction between platelet integrin alphaIIbbeta3 and cytoskeletal protein skelemin." The Journal of biological chemistry 282.44 (2007): 32349-56.
description	19.	Chaudhury, S. "Hsp90 as a Target for Drug Development." ChemMedChem 1.12 (2006): 1331-40.
description	20.	Zhang, L. "7'-Substituted Benzothiazolothio- and Pyridinothiazolothio-Purines as Potent Heat Shock Protein 90 Inhibitors." Journal of medicinal chemistry 49.17 (2006): 5352-5362.